 Your new post is loading...
 Your new post is loading...
|
Scooped by
Ed Rybicki
January 27, 2016 7:05 AM
|
With fears about the Zika virus outbreak in South America spreading, experts are turning toward developing a vaccine that could prevent the spread of the virus.
|
Scooped by
Ed Rybicki
January 26, 2016 10:18 AM
|
To answer questions about the risks of Zika virus infection, researchers need better diagnostics.
|
Scooped by
Ed Rybicki
January 26, 2016 4:08 AM
|
Animal health officials share what dog owners should know about the virus and what to do if their pets come down with it.
|
Scooped by
Ed Rybicki
January 26, 2016 3:10 AM
|
Flu virus hijacking tactics revealed by scientists by Kate Wighton 06 January 2016
Scientists at Imperial College London have discovered how flu viruses 'hijack' cell machinery when they infect the body.
The findings, published in the journal Nature, may pave the way for more effective antiviral treatments for pandemics and for seasonal flu, which infects over 800 million people worldwide every year.
In the research, the team used hamster-chicken hybrid cells to discover why avian influenza virus (bird flu) cannot usually infect mammal cells.
Up until now we haven’t understood why the flu virus has to change in order to hijack the human cell machinery – Professor Wendy Barclay Study Author They found that a particular host protein – called ANP32A – which is also found in human cells, acts as an ‘insider’ and helps the virus replicate once the virus has gained entry into the cell. Bird flu viruses can’t use the mammalian ANP32A unless they carry a particular mutation.
|
Scooped by
Ed Rybicki
January 26, 2016 3:01 AM
|
Inovio Pharma (INO), GeneOne Life Science Enter Collaboration for Zika Virus Vaccine GeneOne Life Science announced the initiation of a collaborative research program with Inovio Pharmaceuticals (Nasdaq: INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection. Inovio and its collaborators are leveraging their past experience in designing and testing novel DNA-based vaccines for related viruses including the West Nile, dengue, and chikungunya viruses. Moreover, Inovio and GeneOne are currently collaborating on two phase I stage vaccine candidates for severe infectious diseases: INO-4212, a vaccine for Ebola infection and GLS-5300, a vaccine for MERS infection. The Zika virus vaccine candidate is currently undergoing preclinical animal studies to evaluate its immunogenicity.
|
Scooped by
Ed Rybicki
January 26, 2016 2:56 AM
|
Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported today in the journal Cell that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
|
Scooped by
Ed Rybicki
January 26, 2016 2:53 AM
|
The guidance emphasizes integrated care for diverse needs of survivors.
|
Scooped by
Ed Rybicki
January 26, 2016 2:32 AM
|
The CDC added eight tropical destinations to a travel alert about an mosquito-borne illness linked with a severe birth defect.
|
Scooped by
Ed Rybicki
January 25, 2016 11:01 AM
|
Brazil's authorities announce plans to prevent the spread of the mosquito-borne Zika virus in Rio de Janeiro during the Olympic Games later this year.
|
Scooped by
Ed Rybicki
January 25, 2016 7:43 AM
|
New research has - once again - appeared to prove the existence of the much-contested 'man flu'. The study, published by researchers at Johns Hopkins University, suggests that the female sex hormone oestrogen could help women combat the virus, leaving lesser-protected men out in the cold. Oestrogen, which is found at considerably higher levels in women than in men, was found to reduce the replication of the 'influenza A' virus in nasal cells, thereby initiating antiviral effects against the disease.
|
Scooped by
Ed Rybicki
January 25, 2016 7:40 AM
|
Researchers have figured out a way to leverage rabies to not kill the brain, but instead map it.
|
Scooped by
Ed Rybicki
January 25, 2016 7:35 AM
|
Focus on the apparent association between Zika infection in pregnant women and the birth of babies with small brains is still largely circumstantial, but if true, is alarming.
|
Scooped by
Ed Rybicki
January 22, 2016 6:24 AM
|
As vaccine manufacturers tackle increasingly intractable pathogens, vaccines will be developed that show efficacy, but that are less efficacious than established vaccines. Consequently, regulatory and public health authorities will be faced with difficult decisions about whether such vaccines should be recommended for implementation and, if so, under what circumstances. The RTS,S/AS01 malaria candidate vaccine provides an important example of such a challenge. After a long period of development,1, 2 a large phase 3 trial3 of RTS,S/AS01 in children aged 5–17 months at first vaccination showed a vaccine efficacy of 28·3% (95% CI 23·3–32·9%) against clinical malaria in children who received three doses, and of 36·3% (31·8–40·5%) in those given a fourth dose, during 48 months of follow-up. The vaccine also provided significant protection against severe malaria and hospital admissions in the group of children who received a fourth dose.3 An average of 1774 cases (95% CI 1387–2186) of clinical malaria were averted per 1000 children vaccinated in the four-dose group. An unexplained increase in incidence of meningitis was identified as a safety signal. Efficacy was lower in infants who received their first dose of vaccine aged 6–12 weeks than in children aged 5–17 months. Could this vaccine with restricted efficacy still have a useful role in malaria control? In The Lancet, Melissa Penny and colleagues4 provide some important new information that suggests that it could.
|
|
Scooped by
Ed Rybicki
January 27, 2016 7:03 AM
|
President Barack Obama on Tuesday called for the rapid development of tests, vaccines and treatments to fight the mosquito-transmitted Zika virus, which has been linked to birth defects and could spread to the United States in warmer months.
|
Scooped by
Ed Rybicki
January 26, 2016 4:22 AM
|
One Russian politician says he expects the vaccine to earn Moscow "billions of dollars."
|
Scooped by
Ed Rybicki
January 26, 2016 3:12 AM
|
It's been known that the HCV α-helical (AH) peptide has broad antiviral properties—the same property that allows the peptide to hijack host cell structures for HCV replication also produces ruptures in viral membranes, exposing the viral genome to host enzymes that destroy the pathogens. However, the development of therapies inspired by the actions of the AH peptide has been limited by the lack of knowledge about why it selectively attacks the viral envelope but not host cell membranes.
|
Scooped by
Ed Rybicki
January 26, 2016 3:04 AM
|
Researchers in the US have developed a virus-like biomaterial that catalyses the formation of hydrogen inexpensively and cleanly, which could lead to new environmentally friendly ways of producing biofuel. The biomaterial is produced by placing a modified enzyme inside the protective protein shell of a virus, called a capsid. The resulting 'nano reactor' catalyst is 150 times more efficient than the unaltered form of the enzyme.
|
Scooped by
Ed Rybicki
January 26, 2016 3:00 AM
|
The European Patent Office on 20 January revoked a patent held by Monsanto on virus-resistant melons for technical reasons, much to the glee of opponents of patents on conventional plants. [updated…
|
Scooped by
Ed Rybicki
January 26, 2016 2:55 AM
|
The U.S. Department of Agriculture (USDA) is taking heat from Congress’s nonpartisan watchdog agency over the way it has responded to outbreaks of so-called emerging diseases in livestock. A U.S. Government Accountability Office (GAO) report faults USDA for not doing enough to respond to and investigate viral outbreaks in pigs in 2013 and 2014, as well as not doing nearly enough afterward to prevent and reduce the impact of future outbreaks. In particular, GAO concluded that USDA erred by not requiring veterinarians and producers to report diseased animals, and by relying on voluntary reports instead. And it warns that new USDA policies aimed at avoiding similar problems in the future may prove difficult to implement. The report specifically refers to what USDA calls emerging diseases—economically damaging diseases that are either new to the United States or appear to be becoming more deadly or dangerous. The findings are important, lawmakers and outside observers say, because they suggest the government is not fully prepared to track and respond to emerging diseases that could harm animal health, push up food prices, and, for some viruses, potentially spread to humans.
|
Scooped by
Ed Rybicki
January 26, 2016 2:37 AM
|
In South Korea last year, a single person spread the virus causing Middle East Respiratory Syndrome (MERS) to 186 others, 36 of whom died as a result. Now Thailand, having identified the virus in a visitor from Oman on Friday (Jan. 22), has since placed dozens of people in quarantine. It's the second MERS case that Thailand...
|
Scooped by
Ed Rybicki
January 26, 2016 2:31 AM
|
Sierra Leone’s army has been requested to assist to better protect the country against the ebola epidemic, following the World Health
|
Scooped by
Ed Rybicki
January 25, 2016 7:45 AM
|
A new drug has shown promise against both Marburg virus and Ebola. This may not be as surprising as it first seems, given the genetic similarities between the two viruses.
|
Scooped by
Ed Rybicki
January 25, 2016 7:42 AM
|
Scientists have discovered they can use the drug rapamycin to freeze the advance of cancer-causing Epstein-Barr virus in cells by putting the cells into a dormant state.
|
Scooped by
Ed Rybicki
January 25, 2016 7:38 AM
|
Experts said that it is just a matter of time before the mosquito-borne Zika virus arrives in the U.S. Here's what could happen once an outbreak occurs.
|
Scooped by
Ed Rybicki
January 22, 2016 7:36 AM
|
A newly emerging disease is threatening the Americas
|
One would hope so...of course, the time to act would have been before it got to S America, let alone N America!